CHICAGO — In this Healio video exclusive, Andrew Armstrong, MD, discusses his presentation from the Genitourinary Cancer session at the ASCO Annual meeting. Armstrong, medical oncologist at Duke Cancer Institute Center for prostate and urologic cancers, presented the results from the use of an AI- derived biomarker in the phase…Read More
VIDEO Practicechanging AIderived biomarker can tailor ADT in highrisk prostate cancer
